Unfortunately, many people interested in using treatments like GLP-1, GLP-1/GIP, or Triple G don't qualify for insurance coverage, meaning they could end up paying more than $1,000 a month out of pocket
Curr Opin Immunol (2000) 12(4):45663
Hernandez C, Bogdanov P, Corraliza L et al (2016) Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes
Monitoring recommendations Researchers using cagrilintide should consider regular monitoring including: Blood work every 3 to 6 months including metabolic panel, lipid panel, liver function, and pancreatic enzymes Thyroid function tests at baseline and periodically Body composition assessment to track lean mass versus fat mass changes Heart rate monitoring particularly during titration Nutritional status markers including vitamin B12, iron, and vitamin D The peptide research and studies section provides broader context for evaluating emerging safety data as it becomes available
Always consult a licensed medical provider regarding health-related questions, and consult licensed contractors, electricians, inspectors, or local authorities for installation, electrical, building code, zoning, HOA, or safety requirements
